News

Mosquito diseases : Stay safe with Moustidose

Mosquito diseases : Stay safe with Moustidose

Vectors of moderate to lethal infectious diseases, mosquitoes are a common nuisance in Mauritius, and proliferate with the advent of summer. Although the island has no recorded indigenous cases of the most dangerous and lethal diseases that can be spread by mosquitoes, Mauritius has borne the brunt of Chikungunya and Dengue fever outbreaks during the past decades.

Chikungunya

According to the World Health Organisation, Chikungunya was first identified in Tanzania in 1952 and stems from the Kimakonde language, meaning “to become contorted”. Its transmission to humans occurs through ‘Tiger’ mosquitoes which are infected with the Chikungunya virus (CHIKV) themselves. Symptoms appear between 2 to 12 days and are characterised by an abrupt onset of fever and joint pains. Other typical signs include headache, nausea, fatigue, muscle pain, joint swelling and rashes. Frequently debilitating, the joint pain may persist for a few days and in some cases, up to several years. Patients appear to be immune from future infections following recovery.

Dengue fever

Prevailing in tropical climates, Dengue fever is a mosquito-borne viral disease having five specific, but closely related serotypes. Infection with one type normally grants immunity to it, and temporary resistance to the others. Diagnostic for Dengue fever spans a broad range, from being asymptomatic, to inducing acute flu-like symptoms such as headaches, high fever, muscle and joint pains. While vomiting and a distinct skin rash are also prevalent, patients rarely develop severe dengue, which may result in bleeding, low blood pressure, reduced levels of blood platelets and plasma that can lead to death. A dengue vaccine is now available worldwide under the name of Dengvaxia.

Prevention is the best safeguard

There is no vaccine for Chikungunya and the infection is managed by treating symptoms. Nonetheless, risks of infection may be avoided by applying Moustidose, a mosquito-repellent expressly developed by Gilbert Laboratories and proven to effectively ward off mosquitoes and ticks. Offering protection for up to 8 hours, Moustidose is available under two variants: a classic spray and a lotion. They are safe to use by adults and children of 30 months and above. A soothing roll-on is also available to alleviate itching following bites.

Unicorn also represents the moustikologne range. This is available in the form of a gas-free spray, the Mousti K.O Zones Tropicales & Infestés lotion protects up to 12 hours against Aedes and 8 hours against Anopheles. It can be used for adults and children from 2 years old. Moustikologne lotion is effective* against mosquitoes that bite during the day, even tiger mosquitoes and those that bite at night. * Proven effective on Aedes aegypti (12 hours), Aedes albopictus (11 hours) and Anopheles stephensi (8 hours).